DocDigest by Design® offering new probiotics for the effective relief of Irritable Bowel Syndrome symptoms

DocDigest by Design® is offering new probiotics, IBS-C (for constipation) and IBS-D (for diarrhea), for the effective relief of Irritable Bowel Syndrome symptoms

HOUSTON, March 14, 2023 /PRNewswire-PRWeb/ -- DocDigest by Design®, a formulator of clinically-trialed probiotics, has announced that it is now offering probiotics effective for relief of symptoms of Irritable Bowel Syndrome, including IBS-C (for constipation) and IBS-D (for diarrhea). Most probiotics now on the market have not been clinically shown to be effective against these IBS symptoms.

DocDigest by Design® markets its products in much the same way as the pharmaceutical industry. Specifically, the probiotic strains in our products are subjected to clinical trials before we offer them for sale to the public. The strains in IBS-C and IBS-D have shown in clinical trials that they are effective at reducing symptoms of constipation or diarrhea. As a result, if IBS is causing you to experience either constipation or diarrhea, you can rest assured that they have passed or exceeded expectations in these clinical trials. The results of the trials are accessible for those who wish to view the specifics. In fact, we publish abstracts of the results of the clinical studies – for both IBS-C and IBS-D – directly on our website.

All probiotics sold by DocDigest by Design® are organic, gluten free, dairy free, and contain no GMO's. Our probiotics are a medical food and should be taken under medical supervision. No prescription is required to purchase either of these products.

For further information about DocDigest by Design® and its products, contact us via email or by telephone.

Media Contact

Ryan Meley, DocDigest by Design®, 1 346-251-1223, [email protected]

SOURCE DocDigest by Design®